AR064788A1 - Compuestos de ciclohexenona de la antrodia comphorata y usos de los mismos - Google Patents

Compuestos de ciclohexenona de la antrodia comphorata y usos de los mismos

Info

Publication number
AR064788A1
AR064788A1 ARP080100073A ARP080100073A AR064788A1 AR 064788 A1 AR064788 A1 AR 064788A1 AR P080100073 A ARP080100073 A AR P080100073A AR P080100073 A ARP080100073 A AR P080100073A AR 064788 A1 AR064788 A1 AR 064788A1
Authority
AR
Argentina
Prior art keywords
compound
ciclohexenone
anthrodia
comphorata
compounds
Prior art date
Application number
ARP080100073A
Other languages
English (en)
Spanish (es)
Inventor
Chung-Chou Chang
Mao-Tien Kuo
Wu-Che Wen
Chun-Hung Huang
Wan-Ling Tsou
Ka-Hang Fok
Ya-Ying Li
Sheng-Yun Liu
Original Assignee
Golden Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golden Biotechnology Corp filed Critical Golden Biotechnology Corp
Publication of AR064788A1 publication Critical patent/AR064788A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/02Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains containing only carbon and hydrogen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fats And Perfumes (AREA)
ARP080100073A 2007-01-08 2008-01-08 Compuestos de ciclohexenona de la antrodia comphorata y usos de los mismos AR064788A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW096100680A TW200829234A (en) 2007-01-08 2007-01-08 Antrodia camphorata isophorone extract

Publications (1)

Publication Number Publication Date
AR064788A1 true AR064788A1 (es) 2009-04-22

Family

ID=38219309

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080100073A AR064788A1 (es) 2007-01-08 2008-01-08 Compuestos de ciclohexenona de la antrodia comphorata y usos de los mismos

Country Status (25)

Country Link
US (1) US7342137B1 (enExample)
EP (1) EP1942093B1 (enExample)
JP (1) JP5085186B2 (enExample)
KR (1) KR101011616B1 (enExample)
AR (1) AR064788A1 (enExample)
AT (1) ATE509005T1 (enExample)
AU (1) AU2008200063C1 (enExample)
BR (1) BRPI0800401A (enExample)
CA (1) CA2618271C (enExample)
CY (1) CY1111722T1 (enExample)
DE (1) DE102007022161A1 (enExample)
DK (1) DK1942093T5 (enExample)
ES (1) ES2365888T3 (enExample)
FR (1) FR2911133A1 (enExample)
GB (1) GB2445430A (enExample)
HR (1) HRP20110588T1 (enExample)
MY (1) MY144944A (enExample)
NO (1) NO20080078L (enExample)
NZ (1) NZ564913A (enExample)
PL (1) PL1942093T3 (enExample)
PT (1) PT1942093E (enExample)
SG (1) SG144815A1 (enExample)
SI (1) SI1942093T1 (enExample)
TW (1) TW200829234A (enExample)
ZA (1) ZA200800150B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI394572B (zh) * 2007-06-12 2013-05-01 Golden Biotechnology Corp Application of Cynanchum aurantii Cyclohexenone Compounds in the Preparation of Drugs for the Treatment of Autoimmune Diseases
TWI394573B (zh) * 2007-06-14 2013-05-01 國鼎生物科技股份有限公司 Application of Cynanchum auranthone Cyclohexenone Compounds in the Preparation of Drugs for Liver Protection
CN101333156B (zh) * 2007-06-27 2011-07-20 国鼎生物科技股份有限公司 牛樟芝环己烯酮化合物的制备方法及其应用
TWI394575B (zh) * 2007-07-09 2013-05-01 Golden Biotechnology Corp Application of Cynanchum auranthone Cyclohexenone Compounds in the Preparation of Drugs for the Suppression of Hepatitis B Virus
JP5203644B2 (ja) * 2007-07-13 2013-06-05 國鼎生物科技股▲ふん▼有限公司 自己免疫疾病の治療に用いるベニクスノキタケ由来の化合物
JP5106935B2 (ja) * 2007-07-17 2012-12-26 國鼎生物科技股▲ふん▼有限公司 生理的疲労の緩和に用いるベニクスノキタケのシクロヘキサンケトン化合物
CN101357883B (zh) * 2007-07-30 2012-09-26 国鼎生物科技股份有限公司 治疗自体免疫疾病的牛樟芝环己烯酮化合物及医药组成物
CN101362679B (zh) * 2007-08-08 2012-05-30 国鼎生物科技股份有限公司 用于抑制b型肝炎病毒的牛樟芝环己烯酮化合物
CN101376624B (zh) * 2007-08-29 2011-06-01 国鼎生物科技股份有限公司 用于护肝的牛樟芝环己烯酮化合物
CN101417934B (zh) * 2007-10-24 2012-04-18 国鼎生物科技股份有限公司 分离自牛樟芝萃取物的化合物
TW201102076A (en) * 2009-07-09 2011-01-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea suppressing growth of tumor cell of osteosarcoma
TW201102075A (en) * 2009-07-09 2011-01-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of pancreatic cancer
TWI383790B (zh) * 2009-09-09 2013-02-01 國鼎生物科技股份有限公司 Used to inhibit the growth of oral cancer cells of the cattle Antrodylcyclohexenone compounds
TWI394566B (zh) * 2009-09-09 2013-05-01 國鼎生物科技股份有限公司 Used to inhibit the growth of ovarian cancer tumor cells of the cattle camphor cyclohexene ketone compounds
TW201109014A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of skin cancer
TWI383791B (zh) * 2009-09-09 2013-02-01 國鼎生物科技股份有限公司 Used to inhibit the growth of gastric cancer tumor cells of the male antler ketone compounds
TW201109023A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of colorectal cancer
TW201109024A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of bladder cancer
TW201109013A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone chemical compounds of Antrodia cinnamomea for suppressing the growth of the Lymphoma tumor cell
EP2329816B1 (en) 2009-11-26 2016-04-13 National Taiwan University An anti-cancer active substance from antrodia camphorata, method for preparing the same and use thereof
US8309611B2 (en) * 2010-09-20 2012-11-13 Golden Biotechnology Corporation Methods and compositions for treating lung cancer
TWI452032B (zh) 2011-01-21 2014-09-11 國鼎生物科技股份有限公司 治療腎病之醫藥組成物
CN103796647A (zh) * 2011-06-10 2014-05-14 国鼎生物科技股份有限公司 用于治疗脑癌的方法和组合物
SE1350211A1 (sv) 2012-02-23 2013-08-24 Golden Biotechnology Corp Metoder och kompositioner för behandling av cancermetastaser
JP6234990B2 (ja) * 2012-03-26 2017-11-22 ゴールデン バイオテクノロジー コーポレーション 動脈硬化性血管疾患を処置するための方法及び組成物
KR102088078B1 (ko) * 2012-11-21 2020-03-12 골든 바이오테크놀러지 코포레이션 신경퇴행성 질환을 치료하기 위한 방법 및 조성물
CN103058846B (zh) * 2013-01-17 2014-07-30 福州大学 一种源于棘孢曲霉的苯醌衍生物及其应用
TWI612026B (zh) * 2013-02-20 2018-01-21 國鼎生物科技股份有限公司 環己烯酮組成物及其製造方法
US20150018296A1 (en) * 2013-03-15 2015-01-15 Golden Biotechnology Corporation Therapeutic methods and compositions utilizing cyclohexenone compounds
TWI583376B (zh) * 2013-03-20 2017-05-21 曾卉菱 Compounds isolated from Antelroxicus and their use
TW201521752A (zh) * 2013-12-05 2015-06-16 國立臺灣師範大學 牛樟芝於抗肥胖的應用及其方法
EP3082779B1 (en) * 2013-12-20 2023-06-07 Biomed Valley Discoveries, Inc. Cancer treatments using combinations of type 2 mek and erk inhibitors
CN104522794B (zh) * 2014-12-04 2017-01-11 深圳市仁泰生物科技有限公司 樟芝解毒饮料及其制备方法
PL3240772T3 (pl) * 2014-12-30 2021-06-28 ONENESS BIOTECH CO., Ltd Związki z antrodia camphorata, sposoby ich otrzymywania i ich zastosowanie
TWI637746B (zh) * 2016-01-20 2018-10-11 台灣利得生物科技股份有限公司 固態培養牛樟芝菌絲體及子實體萃取物之組合物作為腫瘤抑制劑之應用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3064012A (en) * 1960-07-20 1962-11-13 Merck & Co Inc Derivatives of coenzyme q10
WO1986003738A1 (en) * 1984-12-17 1986-07-03 Snader Kenneth M Antiviral and antitumor cyclohexadienone compositions
TWI226370B (en) * 2000-02-17 2005-01-11 Food Industry Res & Dev Inst Isolate of Antrodia camphorata, process for producing a culture of the same and product obtained thereby
US6767543B2 (en) * 2000-02-17 2004-07-27 Council Of Agriculture, Executive Yuan Process for producing a culture of Antrodia camphorata and product obtained thereby
JP5403844B2 (ja) * 2004-03-02 2014-01-29 善笙生物科技股▲分▼有限公司 AntrodiaCamphorataの菌糸体から得た新規な混合物及び化合物、並びにその使用
US7109232B2 (en) * 2004-03-08 2006-09-19 Simpson Biotech Co., Ltd. Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity
TW200638867A (en) * 2005-05-06 2006-11-16 Golden Biotechnology Corp Incubation and application methods for the culture of antrodia camphorata
US20070116787A1 (en) * 2005-11-21 2007-05-24 Chih-Jung Yao Cancer treatment

Also Published As

Publication number Publication date
GB2445430A (en) 2008-07-09
TW200829234A (en) 2008-07-16
CY1111722T1 (el) 2015-10-07
US7342137B1 (en) 2008-03-11
GB0709171D0 (en) 2007-06-20
BRPI0800401A (pt) 2008-08-26
PT1942093E (pt) 2011-08-23
AU2008200063A1 (en) 2008-07-24
EP1942093A1 (en) 2008-07-09
EP1942093B1 (en) 2011-05-11
SG144815A1 (en) 2008-08-28
NZ564913A (en) 2009-05-31
JP5085186B2 (ja) 2012-11-28
NO20080078L (no) 2008-07-09
KR20080065218A (ko) 2008-07-11
DK1942093T5 (da) 2012-04-02
HRP20110588T1 (hr) 2011-11-30
ATE509005T1 (de) 2011-05-15
ES2365888T3 (es) 2011-10-13
SI1942093T1 (sl) 2012-01-31
AU2008200063B2 (en) 2010-01-07
PL1942093T3 (pl) 2011-10-31
AU2008200063C1 (en) 2011-05-19
CA2618271C (en) 2010-08-31
MY144944A (en) 2011-11-30
DE102007022161A1 (de) 2008-07-10
FR2911133A1 (fr) 2008-07-11
JP2008169194A (ja) 2008-07-24
KR101011616B1 (ko) 2011-01-27
TWI330528B (enExample) 2010-09-21
CA2618271A1 (en) 2008-07-08
DK1942093T3 (da) 2011-08-29
ZA200800150B (en) 2009-08-26

Similar Documents

Publication Publication Date Title
AR064788A1 (es) Compuestos de ciclohexenona de la antrodia comphorata y usos de los mismos
ECSP099569A (es) Nuevos derivados de 3-amino-pirrolo[3,4-c]pirazol-5(1h, 4h, 6h)carbaldehído
UY39574A (es) Compuesto macrocíclico útil para tratar el cáncer y composición farmacéutica que lo contiene
NI201500128A (es) 3- pirimidin-4-il-oxazolidin-2-onas como inhibidores de idh mutante
MX2014013858A (es) Metodo para tratar un cancer positivo de gd2.
DOP2009000217A (es) Compuestos organicos y sus usos
MX2013001236A (es) Metodos para el tratamiento de enfermedades neurodegenerativas.
PE20150289A1 (es) Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
AR088983A1 (es) Procedimiento para la preparacion de 5-fluoro-1h-pirazolopiridinas sustituidas
BR112015004089A2 (pt) micro-organismos e métodos para intensificar a disponibilidade de equivalentes de redução na presença de metanol e para produzir 1,4-butanodiol relacionado com os mesmos
MX361458B (es) Compuestos de pirimido-piridazinona y uso de los mismos.
AR085724A1 (es) ANALOGO DE LA SANGLIFERINA CON ACTIVIDAD INHIBIDORA DE mPTP
BRPI0815129B8 (pt) composição radiofarmacêutica, e, métodos para preparação de uma composição radiofarmacêutica
NZ629914A (en) New derivatives of 5-aminolevulinic acid and their use as photosensitizing agents
MX2020004930A (es) Compuestos de biarilo sustituido novedosos como inhibidores de indolamina 2,3-dioxigenasa (ido).
CL2021001869A1 (es) Complejo de gadolinio y un ligando quelatante derivado de pcta diastereoisoméricamente enriquecido y método de síntesis.
IN2013MN01188A (enExample)
AR048938A1 (es) Cepas de levadura que producen colesterol y sus aplicaciones
BR112014002672A2 (pt) composições compreendendo monoésteres de isossorbida e dióis vicinais alifáticos
CO2022014837A2 (es) Células t v delta1+ para el tratamiento de neoplasias mieloides
AR086803A1 (es) Derivados de oxazetidinas, composiciones farmaceuticas y cosmeticas que los contienen y uso de los mismos para tratar enfermedades dermatologicas fundamentalmente, y del aparato respiratorio, digestivo y cardiovascular, entre otras
BRPI0508232A (pt) sìntese de epotilonas, intermediários das mesmas, análogos e usos das mesmas
AR066868A1 (es) 4-fenil-imidazol-2-tionas como inhibidoras de la tirosinasa, su procedimiento de preparacion y su utilizacion en medicina humana como tambien en cosmetica
AR092547A1 (es) Derivados de isoxazolidina
SA119400336B1 (ar) -أيزوأندروجرافوليد-19 (nafld) بروبيونات لمعالجة المرض الكبدي الدهني غير الكحولي

Legal Events

Date Code Title Description
FC Refusal